bringing together oncologists and oncology-focused healthcare professionals across the Empire State
Meetings & Education
Financial Advocacy & Patient Assistance
Off-Label Use Literature
Patient Advocacy Organizations
National Professional Organizations
ESHOS Corporate Members
Become a Supporter
Industry News Archive
CMS Assigns New J-Codes for Rituxan and Rituxan Hycela
Effective January 1, 2019, the Centers for Medicare & Medicaid Services (CMS) has assigned new J-codes for Rituxan and Rituxan Hycela (Genentech, Inc.):
Injection, rituximab, 10 mg (replaces J-code J9310)
Injection, rituximab 10 mg and hyaluronidase
These codes are not all-inclusive; appropriate codes can vary by patient, setting of care and payer. Correct coding is the responsibility of the provider submitting the claim for the item or service. Please check with the payer to verify codes and special billing requirements.
Read more about the new J-codes for Rituxan and Rituxan Hycela here.
Tweets by NY_Oncology